Amedisys (AMED) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
CRMT, More
Financial Fact:
Equity in earnings from unconsolidated joint ventures: 3.24M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q2 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $314.2 million versus the consensus estimate of $307.11 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
- SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
